Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Cancer Research
|
August 15, 1997
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells
A Villunger, A Egle, M Kos, et al.
The EMBO Journal
|
July 22, 1998
Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta
S Kampfer, K Hellbert, A Villunger, et al.
British Journal of Haematology
|
May 1, 1997
Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status
A Egle, A Villunger, I Marschitz, et al.
Stem Cells (Dayton, Ohio)
|
May 1, 1996
2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA)
J Gruber, F Geisen, R Sgonc, et al.
European Journal of Immunology
|
February 5, 1999
Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells
N Ghaffari-Tabrizi, B Bauer, A Villunger, et al.
Cell Death and Differentiation
|
August 14, 2010
BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis
F Grespi, C Soratroi, G Krumschnabel, et al.
British Journal of Haematology
|
September 12, 1998
Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevity
A Villunger, A Egle, M Kos, et al.
Blood
|
July 1, 1997
Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance
A Villunger, A Egle, I Marschitz, et al.
FEBS Letters
|
January 27, 1997
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells
S Geley, B L Hartmann, K Kapelari, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 1999
Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L)
D C Huang, M Hahne, M Schroeter, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Cancer Research
|
August 15, 1997
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells
A Villunger, A Egle, M Kos, et al.
The EMBO Journal
|
July 22, 1998
Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta
S Kampfer, K Hellbert, A Villunger, et al.
British Journal of Haematology
|
May 1, 1997
Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status
A Egle, A Villunger, I Marschitz, et al.
Stem Cells (Dayton, Ohio)
|
May 1, 1996
2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA)
J Gruber, F Geisen, R Sgonc, et al.
European Journal of Immunology
|
February 5, 1999
Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells
N Ghaffari-Tabrizi, B Bauer, A Villunger, et al.
Cell Death and Differentiation
|
August 14, 2010
BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis
F Grespi, C Soratroi, G Krumschnabel, et al.
British Journal of Haematology
|
September 12, 1998
Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevity
A Villunger, A Egle, M Kos, et al.
Blood
|
July 1, 1997
Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance
A Villunger, A Egle, I Marschitz, et al.
FEBS Letters
|
January 27, 1997
The interleukin 1beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells
S Geley, B L Hartmann, K Kapelari, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 1999
Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L)
D C Huang, M Hahne, M Schroeter, et al.
Page
of 6